Form 4 for CAH Cardinal Health
Accepted 2021-08-17 00:00:00 ET · period of report 2021-08-15 · accession 0000721371-21-000082 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-17 | 2021-08-15 | CAH | CRAWFORD VICTOR L. | CEO, Pharmaceutical Segment | A - Grant | $0.00 | +21.3K | 106.3K | +25% | $0 | |
| 2021-08-17 | 2021-08-15 | CAH | CRAWFORD VICTOR L. | CEO, Pharmaceutical Segment | F - Tax | $51.70 | -20.0K | 86.4K | -19% | -$1.03M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2021-08-15 | A | A | 21,277 | $0.00 | 106,347 | D | — | — | |
| 2 | Common | Common Shares | 2021-08-15 | F | D | 19,991 | $51.70 | 86,356 | D | — | — | (F3) Reflects closing price on prior business day. |